On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1 - PubMed (original) (raw)
On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1
S Hoffmeyer et al. Hum Mol Genet. 1995 Aug.
Abstract
The autosomal dominantly inherited disease neurofibromatosis type 1 (NF1) is caused by mutations of a large gene comprising 59 exons, which code for a protein with 2818 amino acids called neurofibromin. Employing an expressed polymorphic site in exon 5 of the neurofibromin gene, the expression of its alleles was analysed quantitatively by scanning radioactive RT-PCR fragments of this exon prepared from the RNA of fibroblast cell cultures from 15 NF1 patients and of white blood cells from one NF1 patient. Thirteen of the RNA preparations yielded unequal amounts of the allelic messages. The deviations of the expression ratios (A2:A1) from 1.0 ranged from -0.9 to +25.8. The allelic messages were equally represented in the RNA preparations from five informative healthy donors. Apart from fibroblasts this phenomenon could also be detected in keratinocytes, melanocytes from normally pigmented skin and melanocytes from a café-au-lait spot of one patient. Only one of three patients affected by stop mutations exhibited unequal allelic expression. When nuclear RNA from 10 of the 13 patients was examined, equal amounts of the primary transcripts were found (average ratio A2/A1: 1.08 +/- 0.07 S.E.M.), indicating that unequal expression on the level of mRNA was not caused by mutations affecting transcriptional regulation. The ratio of the amount of neurofibromin to that of p120 GAP did not seem to be correlated with the extent of unequal allelic expression.
Similar articles
- Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients.
Kaufmann D, Bartelt B, Hoffmeyer S, Müller R. Kaufmann D, et al. Arch Dermatol Res. 1999 Jun;291(6):312-7. doi: 10.1007/s004030050415. Arch Dermatol Res. 1999. PMID: 10421056 - Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
Griesser J, Kaufmann D, Eisenbarth I, Bäuerle C, Krone W. Griesser J, et al. Biol Chem Hoppe Seyler. 1995 Feb;376(2):91-101. doi: 10.1515/bchm3.1995.376.2.91. Biol Chem Hoppe Seyler. 1995. PMID: 7794530 - Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
Böddrich A, Griesser J, Horn D, Kaufmann D, Krone W, Nürnberg P. Böddrich A, et al. Biochem Biophys Res Commun. 1995 Sep 25;214(3):895-904. doi: 10.1006/bbrc.1995.2371. Biochem Biophys Res Commun. 1995. PMID: 7575561 - Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.
Abramowicz A, Gos M. Abramowicz A, et al. Dev Period Med. 2014 Jul-Sep;18(3):297-306. Dev Period Med. 2014. PMID: 25182393 Review. - Molecular genetics of neurofibromatosis type 1 (NF1).
Shen MH, Harper PS, Upadhyaya M. Shen MH, et al. J Med Genet. 1996 Jan;33(1):2-17. doi: 10.1136/jmg.33.1.2. J Med Genet. 1996. PMID: 8825042 Free PMC article. Review.
Cited by
- Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.
Honorato L, Bonilla JJA, Piffer AC, Nimrichter L. Honorato L, et al. Curr Top Microbiol Immunol. 2021;432:121-138. doi: 10.1007/978-3-030-83391-6_10. Curr Top Microbiol Immunol. 2021. PMID: 34972882 - MiR-27a-3p/miR-27b-3p Promotes Neurofibromatosis Type 1 via Targeting of NF1.
Lu H, Liu P, Pang Q. Lu H, et al. J Mol Neurosci. 2021 Nov;71(11):2353-2363. doi: 10.1007/s12031-020-01779-2. Epub 2021 Feb 11. J Mol Neurosci. 2021. PMID: 33570696 - Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.
Kaczorowski JA, Smith TF, Shrewsbury AM, Thomas LR, Knopik VS, Acosta MT. Kaczorowski JA, et al. Behav Genet. 2020 Jul;50(4):191-202. doi: 10.1007/s10519-020-09991-x. Epub 2020 Feb 5. Behav Genet. 2020. PMID: 32026187 Review. - Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1.
Ottenhoff MJ, Rietman AB, Mous SE, Plasschaert E, Gawehns D, Brems H, Oostenbrink R; ENCORE-NF1 Team; van Minkelen R, Nellist M, Schorry E, Legius E, Moll HA, Elgersma Y. Ottenhoff MJ, et al. Genet Med. 2020 May;22(5):889-897. doi: 10.1038/s41436-020-0752-2. Epub 2020 Feb 4. Genet Med. 2020. PMID: 32015538 Free PMC article. - Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H, Mautner VF, Cooper DN. Kehrer-Sawatzki H, et al. Hum Genet. 2017 Apr;136(4):349-376. doi: 10.1007/s00439-017-1766-y. Epub 2017 Feb 17. Hum Genet. 2017. PMID: 28213670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous